ESSA Pharma Inc.: cash_and_restricted_cash
| Value | {"amount": 56320763, "concept": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "currency": "USD"} |
|---|---|
| Period | (as of 2020-09-30) |
| Status | current |
| Entity | ESSA Pharma Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T16:47:45.295254+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/15ebab50-595e-4ec3-80a1-e336ef5cf71c
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001558370-20-014403 · Open the official SEC filing →Retrieved: 2026-08-19T16:47:45.295254+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001633932/cash-and-restricted-cash/2020-09-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/15ebab50-595e-4ec3-80a1-e336ef5cf71c
History
- no predecessors — first report